15. Long term incentive plan | 15. Long term incentive plan The Company’s long term incentive plan (the “LTIP plan”) is restricted to a maximum of 10% of the issued and outstanding common shares. Under the LTIP plan, the Company may grant securities-based incentives including stock options and restricted share units (“RSUs”) to directors, officers, employees, and consultants. The Board of Directors administers the plan and determines the vesting and terms of each grant. Stock Options The Company determined the fair value of stock options using the Black-Scholes option valuation model, which has several inputs including the market price, the exercise price, compound risk free interest rate, annualized volatility, and the number of periods until expiration. The fair value is recorded in equity and expensed through profit and loss over the vesting period. Each stock option entitles the holder to purchase one common share of the Company at the respective exercise price prior to, or on, its expiration date. As of June 30, 2022, the Company had 1,910,000 stock options outstanding (June 30, 2021: 2,780,000) with a weighted average expiration of 1.74 years (June 30, 2021: 2.15), which are exercisable into 1,910,000 common shares (June 30, 2021: 2,780,000) at a weighted average exercise price of USD$2.17 (June 30, 2021: USD$1.73). All the outstanding stock options vested on their respective grant dates. As at As at Award & Vesting Expiration Exercise June 30, June 30, Date Date Price 2021 Awarded Cancelled Exercised 2022 June 9, 2017 June 9, 2022 USD $0.66 900,000 - (25,000 ) (875,000 ) - March 26, 2019 March 26, 2024 CAD $1.00 580,000 - - - 580,000 March 19, 2021 March 19, 2024 CAD $3.60 1,300,000 - - - 1,300,000 May 11, 2022 May 11, 2025 CAD $2.50 - 30,000 - - 30,000 Totals 2,780,000 30,000 (25,000 ) (875,000 ) 1,910,000 The following stock options were granted during the year ended June 30, 2022: (a) On May 11, 2022, the Company granted 30,000 stock options exercisable at a price of CAD$2.50 for a period of three years. The options were valued at $43,050 using the Black-Scholes pricing model based on a risk-free rate of 2.74%, a term of 3 years, volatility of 128% and a market price of $1.93 (CAD$2.50). These stock options vested on the grant date. As at As at Award & Vesting Expiration Exercise June 30, June 30, Date Date Price 2020 Awarded Cancelled Exercised 2021 December 22, 2015 December 22, 2020 USD $0.56 630,001 - (557,826 ) (72,175 ) - June 9, 2017 June 9, 2022 USD $0.66 1,810,000 - (470,000 ) (440,000 ) 900,000 March 26, 2019 March 26, 2024 CAD $1.00 1,185,000 - (315,000 ) (290,000 ) 580,000 March 19, 2021 March 19, 2024 CAD $3.60 - 1,300,000 - - 1,300,000 Totals 3,625,001 1,300,000 (1,342,826 ) (802,175 ) 2,780,000 The following stock options were granted during the year ended June 30, 2021: (a) On March 19, 2021, the Company granted 1,300,000 stock options exercisable at a price of CAD$3.60 for a period of three years. The options were valued at $2,777,404 using the Black-Scholes pricing model based on a risk-free rate of 0.53%, a term of 3 years, volatility of 130% and a market price of $2.88 (CAD$3.60). These stock options vested on the grant date. Restricted share units (RSUs) The fair value of RSUs is based on the grant-day intrinsic value of the shares that are expected to vest by the vesting date. Each RSU entitles the holder to receive a common share of the Company prior to, or on, its expiration date subject to achieving the performance criterion (“milestone”) prior to, or on, its vesting date. The fair value is recorded in equity and expensed through profit and loss over the expected vesting period and is subject to remeasurement at the end of each reporting period based on the probability of achieving the milestone and adjustments for potential forfeitures. As of June 30, 2022, the Company had 270,000 RSUs issued and outstanding (June 30, 2021: 475,000) which entitle the holders to receive 270,000 common shares (June 30, 2021: 475,000) for no additional consideration but are subject to satisfying their respective vesting conditions. The RSUs have a weighted average until vesting of 0.38 years (June 30, 2021: 0.86) and weighted average until expiration of 1.00 years (June 30, 2021: 1.40). A total of $342,880 (2021: $468,844) was expensed as share-based compensation related to vesting or cancellation of RSUs As at As at Grant Vesting Expiration June 30, June 30, Date Date Date 2021 Awarded Cancelled Converted 2022 Vesting condition - Employment on vesting date: March 19, 2021 December 31, 2022 June 30, 2023 200,000 - - - 200,000 May 11, 2022 July 14, 2022 June 30, 2023 - 40,000 - - 40,000 Vesting condition - Milestone achieved on vesting date: March 19, 2021 June 30, 2022 December 31, 2022 125,000 - (125,000 ) - - March 19, 2021 May 17, 2021 December 31, 2021 150,000 - - (150,000 ) - May 11, 2022 July 14, 2022 June 30, 2023 - 30,000 - - 30,000 Totals 475,000 70,000 (125,000 ) (150,000 ) 270,000 The following RSUs were granted during the year ended June 30, 2022: (a) On May 11, 2022, the Company granted 40,000 RSUs with a vesting date of July 14, 2022, whereby the holder will receive 40,000 common shares subject to achieving certain milestones on the vesting date. The grant date fair value was estimated at $77,230 based on a grant-date market price of $1.93 (CAD$2.50). (b) On May 11, 2022, the Company granted 30,000 RSUs with a vesting date of July 14, 2022, whereby the holder will receive 30,000 common shares subject to being employed on the vesting date. These RSUs vested on July 14, 2022. The grant date fair value was estimated at $57,922 based on a grant-date market price of $1.93 (CAD$2.50). The following occurred during the year ended June 30, 2022: (a) A total of 125,000 RSUs did not satisfy their vesting conditions and were cancelled. (b) A total of 150,000 RSUs satisfied their vesting conditions whereby 123,518 were converted into common shares and 26,482 were forfeited to cover payroll deductions owed to the Company by the recipient resulting in a reduction of capital of $70,190. As at As at Grant Vesting Expiration June 30, June 30, Date Date Date 2020 Awarded Cancelled Converted 2021 Vesting condition - Employment on vesting date: March 19, 2021 December 31, 2022 June 30, 2023 - 200,000 - - 200,000 Vesting condition - Milestone achieved on vesting date: December 29, 2020 February 7, 2021 February 19,2021 - 172,481 - (172,481 ) - December 29, 2020 February 7, 2021 August 19, 2021 - 172,481 - (172,481 ) - December 29, 2020 February 7, 2021 February 19, 2022 - 172,481 - (172,481 ) - March 19, 2021 June 30, 2022 December 31, 2022 - 125,000 - - 125,000 March 19, 2021 May 17, 2021 December 31, 2021 - 150,000 - - 150,000 Totals - 992,443 - (517,443 ) 475,000 The following RSUs were granted during the year ended June 30, 2021: (a) On December 29, 2020, the Company granted 517,443 RSUs with variable vesting dates subject to achieving certain milestones prior to expiration whereby 33.33% was set to expire on each of Feb 16, 2021, August 16, 2021, and Feb 16, 2022. The fair value was estimated at $364,852 based on a grant-date market price of CAD$0.90 (USD$0.71). (b) On March 19, 2021, the Company granted the following RSUs: a. 200,000 RSUs with a vesting date of December 31, 2022, whereby the holders will receive 200,000 common shares subject to achieving the vesting condition of being employees or consultants of the Company on the vesting date. The grant date fair value was estimated at $575,352 based on a grant-date market price of $2.88 (CAD$3.60). b. 125,000 RSUs with a vesting date of June 30, 2023, whereby the holders will receive 125,000 common shares subject to achieving the milestone vesting conditions by the vesting date. The grant date fair value was estimated at $359,595 based on a grant-date market price of $2.88 (CAD$3.60). c. 150,000 RSUs with a vesting date of May 17, 2021, whereby the holders will receive 150,000 common shares subject to achieving the milestone vesting condition by the vesting date. The grant date fair value was estimated at $431,514 based on the grant-date market price of $2.88 (CAD$3.60). The following occurred during the year ended June 30, 2021: (a) A total of 517,443 RSUs satisfied their vesting conditions whereby 517,443 were converted into common shares. |